Vaginal Hysterectomy Versus Laparoscopically Assisted Vaginal Hysterectomy for Large Uteri

July 7, 2016 updated by: Ibrahim Mohamed Ibrahim Ali, Ain Shams Maternity Hospital

Vaginal Hysterectomy Versus Laparoscopically Assisted Hysterectomy for Large Uteri ( A Pilot Randomized Clinical Trial)

The investigators compare between Vaginal Hysterectomy and Laparoscopically assisted vaginal hysterectomy in cases of large uteri weighing more than 280 gm regarding operative and Postoperative outcomes

Study Overview

Detailed Description

Study setting : Ain Shams University Maternity Hospital Study Design : Pilot prospective randomized clinical trial Study population: The patients will be recruited from women presenting to the outpatient clinic of Ain Shams University Maternity Hospital planned to undergo hysterectomy for benign cause according to inclusion/ exclusion criteria which will be mentioned later.

Study duration : the study will be carried out during the period from August 2014 to August 2016.

Sample size: total of 50 cases will be included in the study to be divided into two groups, the first group will undergo vaginal hysterectomy and the second will undergo Laparoscopic assisted vaginal hysterectomy.

intervention: after approval of the ethical committee, a detailed explanation of the procedure will be informed to the participant and after her approval to involve in the study, an informed written consent will be taken. Detailed medical history will be obtained from all participants recruited in the study along with complete clinical examination and necessary laboratory and radiological investigations. Each patient will have a case record form in which the data regarding history, examination, investigations, operation costs and postoperative events will be recorded

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Maternity hospital, Ain Shams University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Age between 40 and 70 years.
  2. Uterine weight more than 280gm. the weight will be estimated sonographically using algebraic formula by Kung and Chang expressed in weights and measurements: weight(g)= 50+(4/3 x π(Pi) x L/2 x W/2 x AP/2) where (L) is the length of the uterus from the dome of the fundus to the level of the external os and (W) is the maximum width of the uterus at the level of the cornua and (AP) is the anteroposterior diameter of the uterus . Both (W) and (AP) will be taken perpendicular to the axis of the uterine length.
  3. Presence of a benign cause for hysterectomy. e.g: fibroid uterus, simple endometrial hyperplasia not responding to medical treatment and adenomyosis.

Exclusion Criteria:

  1. Patients medically unfit for laparoscopy as severely compromised cardiac patients.
  2. Obese patients (BMI>30).
  3. Presence of endometriosis.
  4. Previous myomectomy
  5. Presence of adnexal mass
  6. Known or suspected gynecological malignancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: VH
Vaginal Hysterectomy for uteri larger than 280gm

All the cases were performed by the same surgical team

  1. Incision is made at the anterior cervical lip below the bladder reflection
  2. Anterior peritoneal entry .
  3. Douglas pouch entry.
  4. The uterosacral ligaments and the cardinal ligaments are clamped, divided and ligated .
  5. Uterine artery clamping division and ligation
  6. After securing the uterine A., debulking procedures was performed in the form of bisection, coring or myomectomy
  7. Utero-ovarian and round clamping-division and ligation ( in cases where oophorectomy was performed this part was done at the level of the infundibulo-pelvic ligament).
  8. Hemostasis
  9. The vaginal vault is closed after insertion of intraperitoneal drain and
Active Comparator: LAVH
Laparoscopic assisted vaginal hysterectomy for uteri larger than 280gm
  1. Uterine manipulator was inserted through the cervix to mobilize the uterus
  2. Veress needle was inserted through the base of the umbilicus
  3. creation of pneumoperitoneum
  4. Insertion of 4 trocars one at the base of umbilicus for the camera and 3 lateral trocars
  5. The round and the utero-ovarian ligament are coagulated and divided.
  6. Dissection through the vesico-uterine space to displace bladder away from the cervix.
  7. Uterine artery was coagulated and divided laparoscopically
  8. anterior colpotomy over the cup of the uterine elevator.
  9. Vaginal part starts with opening of douglas pouch and clamping , division and ligation of uterosacral and cardinal ligaments followed by removal of the uterus and closure of the vault. reinflation to ensure proper hemostasis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operative time of the procedure
Time Frame: Range from 90 minutes to 210 minutes
In case of vaginal hysterectomy, the operative time will be measured from the vaginal incision to closure of the vaginal vault. in cases of Laparoscopic assisted vaginal hysterectomy, the time will be measured from the introduction of the laparoscopic camera port till stitching the laparoscopic incisions after ensuring adequate hemostasis. the time of any concomitant procedures was excluded
Range from 90 minutes to 210 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Estimated intraoperative blood loss
Time Frame: the operative time of the procedure which range from 90 minutes to 210 minutes

intraoperative blood loss will be estimated via:

  1. - amount of blood in suction bottle.
  2. - Estimation based on number of soaked gauzes by weighing the gauzes used in the procedure before and after surgery ( each 1mg corresponds to 1ml of blood)
  3. - Drop in postoperative hemoglobin and hematocrit when compared with preoperative values.
the operative time of the procedure which range from 90 minutes to 210 minutes
Hospital costs
Time Frame: within the period of hospital admission which range from 2 to 8 days

the costs of the following will be calculated:

  1. - Admission cost which include ward fee, pre and postoperative management costs and extra charges for post surgical complication.
  2. - anesthesia cost which includes expenses of anesthetics during the procedure. C)- operation cost which include operative material fee.
within the period of hospital admission which range from 2 to 8 days
intraoperative complications
Time Frame: the operative time of the procedure which range from 90 minutes to 210 minutes
  1. - need for blood transfusion
  2. - need for laparotomy due to either surgical difficulty or any complication
  3. - Bowel or urinary tract injuries
the operative time of the procedure which range from 90 minutes to 210 minutes
Postoperative Pain
Time Frame: the first 24hrs after the procedure
Postoperative pain will be assessed using the visual analogue scale after the procedure by 6hrs, 12hrs and 24hrs.
the first 24hrs after the procedure
Postoperative complications
Time Frame: 1 month after the procedure
  1. - Need for blood transfusion
  2. - Vaginal vault or pelvic hematoma
  3. - surgical site infection
  4. - urinary tract infection
  5. - postoperative bowel or urinary tract complications
1 month after the procedure
postoperative hospital stay
Time Frame: range from 24 hours to 168 hours
the hospital stay will be measured in hours
range from 24 hours to 168 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Fekrya A Salama, PhD, Ain shams university maternity hospital
  • Study Director: Ahmed A Tharwat, PhD, Ain shams university maternity hospital
  • Study Director: Walid E Mohamed, PhD, Ain shams university maternity hospital
  • Study Director: Ibrahim M Ibrahim, PhD, Ain shams university maternity hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Actual)

May 1, 2016

Study Completion (Anticipated)

July 1, 2016

Study Registration Dates

First Submitted

June 28, 2016

First Submitted That Met QC Criteria

July 6, 2016

First Posted (Estimate)

July 7, 2016

Study Record Updates

Last Update Posted (Estimate)

July 11, 2016

Last Update Submitted That Met QC Criteria

July 7, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Minimally Invasive Hysterectomy in Large Uteri

Clinical Trials on Vaginal hysterectomy

3
Subscribe